CARDIOMYOPATHY
Clinical trials for CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene therapy for rare heart condition put on hold before it began
Disease control TerminatedThis study was designed to test a new gene therapy called ASP2016 for heart problems in people with Friedreich Ataxia, a rare genetic disease. The goal was to check safety and how well people tolerated the treatment, which involved a single infusion plus steroids to protect the t…
Matched conditions: CARDIOMYOPATHY
Phase: PHASE1 • Sponsor: Astellas Gene Therapies • Aim: Disease control
Last updated May 17, 2026 05:05 UTC
-
Weight-Loss drug semaglutide could be key to treating Obesity-Linked heart failure
Symptom relief ENROLLING_BY_INVITATIONThis study looks at whether aggressive weight loss using semaglutide can improve symptoms in people with a specific type of heart failure linked to obesity. About 81 participants with a BMI of 30 or higher will receive either semaglutide or a placebo. The main goal is to measure …
Matched conditions: CARDIOMYOPATHY
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated May 04, 2026 16:29 UTC
-
10,000-Patient heart registry launches to improve ablation outcomes
Knowledge-focused ENROLLING_BY_INVITATIONThis study is a large international registry that will collect information from 10,000 people who are having a heart procedure called catheter ablation for ventricular tachycardia (a fast, abnormal heart rhythm) or related conditions. The goal is to track how well the procedure w…
Matched conditions: CARDIOMYOPATHY
Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated May 17, 2026 05:26 UTC